Tabula Rasa HealthCare, a provider of individualized technology solution to decrease adverse drug events (ADEs), filed on Monday with the SEC to raise up to $115mm in an initial public offering.
The Moorestown, NJ-based company, which was founded in 2011 and booked $64 million in sales for the 12 months ended September 30, 2015, plans to list on the Nasdaq under the symbol TRHC. Tabula Rasa HealthCare filed confidentially on 11/15/2013. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray are the joint bookrunners on the deal. No pricing terms were disclosed.
